Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judi Profant

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Hypertension|May 7, 2002
Nocturnal blood pressure dipping and beta-adrenergic receptor sensitivityJudi Profant, Paul J Mills, Joel E Dimsdale
Heart & Lung : the Journal of Critical Care|February 7, 2003
A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of lifeJudi Profant, Sonia Ancoli-Israel, Joel E Dimsdale
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 10, 2002
Are there ethnic differences in sleep architecture?Judi Profant, Sonia Ancoli-Israel, Joel E Dimsdale
Nature and Science of Sleep|October 6, 2023
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice PerspectiveAsim Roy, Diane Ito, Susan Morris, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 2, 2020
Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsyAatif M Husain, Shay Bujanover, Robert Ryan, et al.
Drugs - Real World Outcomes|January 13, 2021
The Xyrem<sup>®</sup> (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017Michael J Strunc, Jed Black, Prasheel Lillaney, et al.
Expert Opinion on Drug Discovery|November 24, 2021
Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomniaGunjan Junnarkar, Clark Allphin, Judi Profant, et al.
Sleep Medicine|December 17, 2019
Burden of disease in pediatric narcolepsy: a claims-based analysis of health care utilization, costs, and comorbiditiesGinger Carls, Sheila Reiss Reddy, Michael S Broder, et al.
Sleep Medicine|December 17, 2021
Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 yearsY Grace Wang, Diane Menno, Abby Chen, et al.
Sleep Medicine|July 14, 2022
Validation of the Pediatric Narcolepsy Screening Questionnaire (PNSQ): A cross-sectional, observational studySusan Morris, Giuseppe Plazzi, Christine de la Loge, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Hypertension|May 7, 2002
Nocturnal blood pressure dipping and beta-adrenergic receptor sensitivityJudi Profant, Paul J Mills, Joel E Dimsdale
Heart & Lung : the Journal of Critical Care|February 7, 2003
A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of lifeJudi Profant, Sonia Ancoli-Israel, Joel E Dimsdale
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 10, 2002
Are there ethnic differences in sleep architecture?Judi Profant, Sonia Ancoli-Israel, Joel E Dimsdale
Nature and Science of Sleep|October 6, 2023
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice PerspectiveAsim Roy, Diane Ito, Susan Morris, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 2, 2020
Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsyAatif M Husain, Shay Bujanover, Robert Ryan, et al.
Drugs - Real World Outcomes|January 13, 2021
The Xyrem<sup>®</sup> (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017Michael J Strunc, Jed Black, Prasheel Lillaney, et al.
Expert Opinion on Drug Discovery|November 24, 2021
Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomniaGunjan Junnarkar, Clark Allphin, Judi Profant, et al.
Sleep Medicine|December 17, 2019
Burden of disease in pediatric narcolepsy: a claims-based analysis of health care utilization, costs, and comorbiditiesGinger Carls, Sheila Reiss Reddy, Michael S Broder, et al.
Sleep Medicine|December 17, 2021
Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 yearsY Grace Wang, Diane Menno, Abby Chen, et al.
Sleep Medicine|July 14, 2022
Validation of the Pediatric Narcolepsy Screening Questionnaire (PNSQ): A cross-sectional, observational studySusan Morris, Giuseppe Plazzi, Christine de la Loge, et al.
Pageof 1